Antibiotic Impregnated Urinary Catheters vs Regular Urinary Catheters: Do They Prevent More Infections in ICU?

Comparison of antibiotic-impregnated urinary catheters versus standard urinary catheters in preventing catheter-associated urinary tract infection among short-term indwelling ICU patients: A prospective randomised study - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/06/112525

Enrollment

100

Registered

2026-06-11

Start date

Unknown

Completion date

Unknown

Last updated

2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N00-N99- Diseases of the genitourinary system

Interventions

Intervention1: Antibiotic impregnated foleys catheter: Nitrofurazone antibiotic coating Inserted on day 1 of ICU admission and observed for development of UTI. Control Intervention1: Standard foleys

Eligibility

Inclusion criteria

Inclusion criteria: Patients admitted to ICU requiring short-term indwelling urinary catheterization LESS THAN 14 DAYS Patients consenting for participation in the study

Exclusion criteria

Exclusion criteria: Age LESS THAN 18 years. Patients with symptoms or laboratory evidence of UTI at the time of ICU admission Patients with history of long-term catheter use Patients with structural urinary tract abnormalities or recent urological surgery Patients receiving antibiotics specifically for UTI at admission

Design outcomes

Primary

Measure	Time frame
To compare the incidence of catheter-associated urinary tract infection (CAUTI) among short-term indwelling ICU patients using antibiotic-impregnated urinary catheters versus standard urinary catheters in a tertiary care centre.Timepoint: at baseline; on the day of fever or UTI symptoms develop before 14 days , if not , then at 14 days.	—

Secondary

Measure	Time frame
To assess the spectrum of microorganisms & antimicrobial susceptibility patterns associated with CAUTI in both catheter groups. To evaluate clinical outcomes including duration of catheterization, need for antibiotic escalation, length of ICU stay, & catheter-related complications. To identify patient-related & procedure-related factors that may influence the risk of CAUTI. To document any adverse reactions or intolerance specifically attributable to the antibiotic-impregnated urinary catheter during the study period. Timepoint: at baseline,on the day of fever or UTI symptoms that develop before 14 days if not,then at 14 days	—

Measure

Time frame

To assess the spectrum of microorganisms & antimicrobial susceptibility patterns associated with CAUTI in both catheter groups. To evaluate clinical outcomes including duration of catheterization, need for antibiotic escalation, length of ICU stay, & catheter-related complications. To identify patient-related & procedure-related factors that may influence the risk of CAUTI. To document any adverse reactions or intolerance specifically attributable to the antibiotic-impregnated urinary catheter during the study period. Timepoint: at baseline,on the day of fever or UTI symptoms that develop before 14 days if not,then at 14 days

—

Countries

India

Contacts

Public ContactDR Riyaz Mohammed M

Bangalore medical college and research institute.

viji2751977@gmail.com9886504680

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 29, 2026